Cargando…
Comparative mutational landscape analysis of patient-derived tumour xenografts
BACKGROUND: Screening of patients for cancer-driving mutations is now used for cancer prognosis, remission scoring and treatment selection. Although recently emerged targeted next-generation sequencing-based approaches offer promising diagnostic capabilities, there are still limitations. There is a...
Autores principales: | Brait, Mariana, Izumchenko, Evgeny, Kagohara, Luciane T, Long, Samuel, Wysocki, Piotr T, Faherty, Brian, Fertig, Elana J, Khor, Tin Oo, Bruckheimer, Elizabeth, Baia, Gilson, Ciznadija, Daniel, Sloma, Ido, Ben-Zvi, Ido, Paz, Keren, Sidransky, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318980/ https://www.ncbi.nlm.nih.gov/pubmed/28118322 http://dx.doi.org/10.1038/bjc.2016.450 |
Ejemplares similares
-
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
por: Izumchenko, Evgeny, et al.
Publicado: (2015) -
Adenoid cystic carcinoma: emerging role of translocations and gene fusions
por: Wysocki, Piotr T., et al.
Publicado: (2016) -
Patient-derived xenografts for individualized care in advanced sarcoma
por: Stebbing, Justin, et al.
Publicado: (2014) -
Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes
por: Loyo, M, et al.
Publicado: (2012) -
Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients
por: Zhu, Qingsong, et al.
Publicado: (2015)